Feasibility, Efficacy, And Safety Of Using Dolutegravir/Lamivudine (Dtg/3tc) As A First-Line Regimen In A Test-And-Treat Setting For Newly Diagnosed People Living With Hiv (Plwh): The Stat Study
INFECTION(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要